Showing results (361-370 of 2,810) with videos related to
Sort By:
Pageof 281
Expert Opinion on Drug Safety|September 18, 2014
Hormonal contraception, thrombosis and ageØjvind LidegaardExpert Opinion on Drug Safety|January 8, 2015
Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medicationsBruno Halpern, Alfredo HalpernExpert Opinion on Drug Safety|November 20, 2014
Safety of anti-TNF therapy in inflammatory bowel disease during pregnancyNabeel Khan, Hamna Asim, Gary R LichtensteinExpert Opinion on Drug Safety|October 24, 2014
A safety evaluation of canagliflozin : a first-in-class treatment for type 2 diabetesLuke D Boyle, John P H WildingExpert Opinion on Drug Safety|December 19, 2014
Safety issues and concerns of new immunomodulators in rheumatologyCarlo Selmi, Angela Ceribelli, Stanley M Naguwa, et al.Expert Opinion on Drug Safety|January 20, 2015
Umeclidinium/vilanterol combination inhaler efficacy and potential impact on current chronic obstructive pulmonary disease management guidelinesJames F Davidson, James F Donohue, Jill A OharExpert Opinion on Drug Safety|July 28, 2015
Primary biliary cirrhosis: safety and benefits of established and emerging therapiesJames H Tabibian, Keith D LindorExpert Opinion on Drug Safety|September 2, 2017
The safety of edoxaban for treating atrial fibrillationMatthias Hammwöhner, Andreas GoetteExpert Opinion on Drug Safety|October 14, 2017
Psychotropic drugs and CYP2D6 in late-life psychiatric and neurological disorders. What do we know?Davide Seripa, Madia Lozupone, Eleonora Stella, et al.Expert Opinion on Drug Safety|September 12, 2015
Metformin: risk-benefit profile with a focus on cancerNicoletta Provinciali, Matteo Lazzeroni, Massimiliano Cazzaniga, et al.Pageof 281